Various lysates were subjected to SDS PAGE followed by western blot with CL594-66009 (Beta Actin antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.
Immunofluorescent analysis of (-20°C Methanol) fixed MDCK cells using CoraLite®594 Beta Actin antibody (CL594-66009, Clone: 2D4H5 ) at dilution of 1:200.
Immunofluorescent analysis of (-20°C Methanol) fixed HepG2 cells using CoraLite®594 Beta Actin antibody (CL594-66009, Clone: 2D4H5 ) at dilution of 1:200.
1x10^6 HeLa cells were intracellularly stained with 0.8 ug CoraLite®594-conjugated Beta Actin Monoclonal antibody (CL594-66009, Clone:2D4H5)(red), or 0.8 ug CoraLite®594 Mouse IgG2b Isotype Control (MPC-11) (CL594-65128, Clone: MPC-11) (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).
Immunofluorescent analysis of (-20°C Methanol) fixed HeLa cells using CoraLite®594 PEX14 antibody (CL594-10594) at dilution of 1:400, CoraLite®488 Beta Actin antibody (CL488-66009, Clone: 2D4H5, green).
1X10^6 HeLa cells were intracellularly stained with 0.8 ug CoraLite®594 Anti-Human PEX14 (CL594-10594) (red), or 0.8 ug Isotype Control. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).
Immunofluorescent analysis of HepG2 cells using 19842-1-AP (hIST1 antibody) at dilution of 1:25 and SA00013-4 CoraLite594-conjugated Goat Anti-Rabbit IgG(H+L).
Immunofluorescent analysis of (-20°C Acetone) fixed HeLa cells using 10298-1-AP (Lamin A/C antibody) at dilution of 1:100 and CL594-66467 (CL594-Mouse anti-Rabbit IgG heavy chain) as secondary antibody with dilution 1:400. .
Immunofluorescent analysis of (4% PFA) fixed HepG2 cells using CoraLite®594 Heavy chain of Rabbit IgG antibody (CL594-66467, Clone: 1C9A5 ) at dilution of 1:500.
Various lysates were subjected to SDS PAGE followed by western blot with CL594-60004 (GAPDH antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours.
1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®594 Anti-Human GAPDH (CL594-60004, Clone:1E6D9) (red), or 0.4 ug Mouse IgG2b Isotype Control (CL594-66360-3, Clone: K11B8C4B5) (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).
Various lysates were subjected to SDS PAGE followed by western blot with CL594-66031 (Alpha Tubulin antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.
Immunofluorescent analysis of (-20°C Ethanol) fixed HepG2 cells using CL594-66031 (alpha Tubulin antibody) at dilution of 1:100.
Immunofluorescent analysis of (4% PFA) fixed HeLa cells using the CoraLite®594-conjugated version of this antibody, CL594-66031 (alpha Tubulin antibody), at dilution of 1:100.
1X10^6 HepG2 cells were intracellularly stained with 0.8 ug CoraLite®594 Anti-Human Alpha Tubulin (CL594-66031, Clone:1E4C11) (red), or 0.8 ug Mouse IgG2b Isotype Control (CL594-66360-3, Clone: K11B8C4B5) (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).
Various lysates were subjected to SDS PAGE followed by western blot with CL594-60008 (Beta Actin antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.
Immunofluorescent analysis of (-20°C Methanol) fixed HeLa cells using CoraLite®594 Beta Actin antibody (CL594-60008, Clone: 7D2C10 ) at dilution of 1:200.
Immunofluorescent analysis of (4% PFA) fixed SH-SY5Y cells using the CoraLite®594-conjugated version of this antibody, CL594-66240 (beta Tubulin antibody), at dilution of 1:100.
1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®594 Anti-Human Beta Tubulin (CL594-66240, Clone:1D4A4) (red), or 0.4 ug CoraLite®594 Mouse IgG2a Isotype Control (C1.18.4) (CL594-65208, Clone: C1.18.4) (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).
Immunofluorescent analysis of (-20°C Ethanol) fixed HepG2 cells using CoraLite®594 Lamin B1 antibody (CL594-66095, Clone: 3C10G12 ) at dilution of 1:200.
1X10^6 HeLa cells were intracellularly stained with 0.8 ug CoraLite®594 Anti-Human Lamin B1 (CL594-66095, Clone:3C10G12) (red), or 0.8 ug CoraLite®594 Mouse IgG1 Isotype Control (MOPC-21) (CL594-65124, Clone: MOPC-21) (blue). Cells were fixed and permeabilized with Transcription Factor Staining Buffer Kit (PF00011).
Immunofluorescent analysis of (4% PFA) fixed human breast cancer tissue using CoraLite®594 VE-cadherin antibody (CL594-66804, Clone: 4F9B10 ) at dilution of 1:100.
Immunofluorescent analysis of (4% PFA) fixed HeLa cells using 66031-1-Ig (alpha tubulin antibody) and CoraLite®594 mouse IgG Kappa Light Chain antibody (SA00014-2) at dilution of 1:500. DAPI (blue).
Immunofluorescent analysis of (-20°C Methanol) fixed HepG2 cells using CoraLite®594 Arginase-1 antibody (CL594-66129, Clone: 5D6D12 ) at dilution of 1:200.
1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®594 Anti-Human ATF4 (CL594-60035, Clone:3E4C5) (red), or 0.4 ug CoraLite®594 Mouse IgG1 Isotype Control (MOPC-21) (CL594-65124, Clone: MOPC-21) (blue). Cells were fixed and permeabilized with True-Nuclear Transcription Factor Buffer Set.
Immunofluorescent analysis of (4% PFA) fixed human liver cancer tissue using CoraLite®594 CD107a antibody (CL594-67300, Clone: 3B2E9 ) at dilution of 1:200.
Immunofluorescent analysis of (4% PFA) fixed human liver cancer tissue using CoraLite®594 CD107a antibody (CL594-67300, Clone: 3B2E9 ) at dilution of 1:200.
Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CoraLite®594 CD11c/Integrin Alpha X antibody (CL594-60258, Clone: 2F1C10 ) at dilution of 1:200.
Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CoraLite®594 CD11c/Integrin Alpha X antibody (CL594-60258, Clone: 2F1C10 ) at dilution of 1:200.
